Video
Carlos Aquino, founder and president of PharmaDiversion LLC, reviews some of the DEA's requirements for handling controlled substances.
Carlos Aquino, founder and president of PharmaDiversion LLC, reviews some of the DEA’s requirements for handling controlled substances.
This video was recorded at the 2015 NCPA Annual Convention.
FDA Grants Approval to Generic Extended-Release Memantine/Donepezil and Everolimus